 |
|
|
|
Making Connections Around the Region
|
 |
|
|
It has been a busy few months at the Boston Innovation Center, connecting with innovators across the northeast region. In July, our team took to the seas with New York BIO's summer cruise and organized a selfie scavenger hunt for passengers.We kicked off the fall conference season in September, when Tom Luby, Marian Nakada, Erin Washington, and V. Kadir Kadhiresan spoke at the RESI Boston Conference and Cris Deluca, Barry Fitzsimons, Kuldeep Neote took the stage at BioPharm America, exploring topics ranging from deal making to digital health. Additionally, PharmaVOICE named Robert Urban, PhD, and Marianne De Backer, PhD, among the 2016 PharmaVOICE 100 for their work removing barriers to innovation and excellence in deal-making.
|
|
|
|
Meet Robert Radinsky, PhD,
of the Boston Innovation Center
|
|
Visit
Let's Talk Innovation
to hear from Robert about his role at Johnson & Johnson Innovation as
the Vice President of Oncology Scientific Innovation, and exciting opportunities for growth and innovation in this space.
|
|
|
| Breakthrough Medical Device Technologies |
|
|
Johnson & Johnson Innovation has created the
Center for Device Innovation
at Texas Medical Center (CDI @ TMC) that aims to accelerate end-to-end development of breakthrough medical devices. Internationally renowned cardiac surgeon, William E. "Billy" Cohn will lead the center.
|
|
|
 |
 |
|
What Inspires Women in Science
|
 |
|
|
At the beginning of September, when students went back to school,
STAT asked some of Johnson & Johnson's top women leaders what inspired them to study science at a young age, and put them on a path to where they are today. Participants include Anuk Das, PhD, Head of Scientific Innovation, Janssen Human Microbiome Institute, based in Boston, Ann van Dessel, Senior Vice President of Enterprise Global Clinical Operations, Johnson & Johnson, based in Antwerp, Belgium, Widya Mulyasasmita, Manager, Johnson & Johnson Innovation New Ventures, based in Menlo Park, California and Marion Vetter, MD, RD, MS, Global Vice President of Cardiovascular & Metabolism Translational & Experimental Medicine at Janssen, based in Philadelphia.
|
|
|
 |
|
Partner Spotlight and Recent News
|
|
JLABS @ Toronto company KalGene Pharmaceuticals announced an agreement with the National Research Council of Canada (NRC) to develop and manufacture a promising Alzheimer's treatment in Canada that has been under development since 2015. Canadians with Alzheimer's disease will be the first patients to receive the treatment, a custom-engineered therapeutic developed at NRC.
|
|
 |
|
|
|
|
FierceBiotech named Johnson & Johnson Innovation partner and JLABS alumni Vedanta Biosciences to its 2016 Fierce 15 for its work developing innovative class of therapies that modulate pathways of interaction between the human microbiome and host immune system. The annual Fierce 15 is comprised of biopharmaceutical companies who exemplify innovation and embody Fierce. Vedanta is recognized for its focus not only on diseases traditionally linked to the microbiome, such as autoimmune and infectious disease, but cancer, as well.
|
|
 |
|
|
|
|
|
Johnson & Johnson launched the Africa Innovation Challenge to drive entrepreneurship and help advance promising consumer healthcare solutions. Chosen applicants will receive a combination of awards including funding up to US $100,000, potential lab space in Africa, and/or mentoring from a select few at Johnson & Johnson to help bring their idea to life and create meaningful change in their community or country.
|
|
 |
|
|
|
|
In
September,
Janssen Business Development
co-hosted
Boston Biotech Conferences
' first-ever
Anti-Infectives Rx
, a networking forum featuring discussion panels from industry CEOs, life science leaders, key academics and investors. The program focused on issues facing the development of anti-infective, antiviral, and antibacterial therapies, and covered regulatory issues, sustainability, partnering, as well as microbiome and immunotherapy as the new wave of anti-infectives. Team members served as moderators and panelists sharing their perspectives on collaborative opportunities to advance new transformative health solutions.
|
|
 |
|
|
|
|
|
SOLD OUT - Follow link to join the
wait list.
Sell Your Science - Best Practices for Developing an Effective Non-Confidential Pitch Deck
|
|
 |
|
|
|
|
Seal the Deal for your Medical Device: Alternative Funding Streams
|
|
 |
|
|
From Chemical to Drug - The Path to a Small Molecule IND
|
|
 |
|
|
|
|
|
|
|
|
|
 |
|